Nike, Inc.'s continued revitalization of its 2000s Air Jordan "Rare Air" series is continuing this spring with the launch of ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

Geotab 2024 sustainability report finds that cost and efficiency are the main drivers of action LONDON, March 28, 2025 /PRNewswire/ -- Companies are more likely to adopt sustainable initiatives if ...

HII’s Ingalls Shipbuilding division successfully launched future USS Jeremiah Denton (DDG 129), the third Flight III Arleigh Burke-class destroyer to be built at the shipyard. Shipbuilders transferred ...

FUVEAU, France, March 19, 2025 /PRNewswire/ -- Plasmalex, a leader in advanced coating solutions, proudly introduces PlasmaGuard X, the newest innovation in its PlasmaGuard® platform of high ...

University of Virginia President Emeritus John T. Casteen III, who led the University for 20 years and was known for growing UVA’s student body, faculty and global reputation, died Tuesday after a ...

HyperX’s latest model has a boom mic for gaming, and a hidden omni-directional mic for regular headphones use. HyperX’s latest model has a boom mic for gaming, and a hidden omni-directional ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Britain’s King Charles III waves as he arrives ...

Rumors suggest a revised May 2025 launch for the EOS R6 Mark III It could inherit features from the pricier EOS R5 Mark II As a potential EOS R6 Mark II update, it rivals the Nikon Z6 III and Sony ...

Paradox have announced Crusader Kings III: Chapter IV, the next expansion pass for their popular strategy game. One DLC is already available, with the next major expansion due out April 28th. Crusader ...

High-level results from the CALYPSO Phase III trial showed that eneboparatide, AZP-3601, an investigational parathyroid hormone receptor 1 agonist, met its primary endpoint with statistical ...